Related references
Note: Only part of the references are listed.TET3 promotes AML growth and epigenetically regulates glucose metabolism and leukemic stem cell associated pathways
Alex Jose Pulikkottil et al.
LEUKEMIA (2022)
Complex landscape of alternative splicing in myeloid neoplasms
Courtney E. Hershberger et al.
LEUKEMIA (2021)
The function and regulation of TET2 in innate immunity and inflammation
Boyi Cong et al.
PROTEIN & CELL (2021)
TETology: Epigenetic Mastermind in Action
Ashikh Seethy et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2021)
A Therapeutic Strategy for Preferential Targeting of TET2-Mutant and TET Dioxygenase-Deficient Cells in Myeloid Neoplasms
Yihong Guan et al.
BLOOD CANCER DISCOVERY (2021)
Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patients
Giacomo Coltro et al.
LEUKEMIA (2020)
Expression and prognosis analysis of TET family in acute myeloid leukemia
Tingjuan Zhang et al.
AGING-US (2020)
Machine learning demonstrates that somatic mutations imprint invariant morphologic features in myelodysplastic syndromes
Yasunobu Nagata et al.
BLOOD (2020)
Context dependent effects of ascorbic acid treatment in TET2 mutant myeloid neoplasia
Yihong Guan et al.
COMMUNICATIONS BIOLOGY (2020)
Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma
Niraj Shenoy et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Dysregulation of the TET family of epigenetic regulators in lymphoid and myeloid malignancies
Chan-Wang J. Lio et al.
BLOOD (2019)
Invariant phenotype and molecular association of biallelic TET2 mutant myeloid neoplasia
Hassan Awada et al.
BLOOD ADVANCES (2019)
Consequences of mutant TET2 on clonality and subclonal hierarchy
Cassandra M. Hirsch et al.
LEUKEMIA (2018)
Metabolism, Activity, and Targeting of D- and L-2-Hydroxyglutarates
Dan Ye et al.
TRENDS IN CANCER (2018)
TET proteins regulate the lineage specification and TCR-mediated expansion of iNKT cells
Ageliki Tsagaratou et al.
NATURE IMMUNOLOGY (2017)
5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia
Jae-Sook Ahn et al.
ONCOTARGET (2017)
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
S. Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells
Feng Pan et al.
NATURE COMMUNICATIONS (2017)
Distinct roles for TET family proteins in regulating human erythropoiesis
Hongxia Yan et al.
BLOOD (2017)
TET2 expression level and 5-hydroxymethylcytosine are decreased in refractory cytopenia of childhood
Diego F. Coutinho et al.
LEUKEMIA RESEARCH (2015)
Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6
Qian Zhang et al.
NATURE (2015)
Acute loss of TET function results in aggressive myeloid cancer in mice
Jungeun An et al.
NATURE COMMUNICATIONS (2015)
Overlapping Requirements for Tet2 and Tet3 in Normal Development and Hematopoietic Stem Cell Emergence
Cheng Li et al.
CELL REPORTS (2015)
Combined Loss of Tet1 and Tet2 Promotes B Cell, but Not Myeloid Malignancies, in Mice
Zhigang Zhao et al.
CELL REPORTS (2015)
Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells
H. Dolatshad et al.
LEUKEMIA (2015)
Characterization of acute myeloid leukemia based on levels of global hydroxymethylation
Leonie I. Kroeze et al.
BLOOD (2014)
The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases
E. Solary et al.
LEUKEMIA (2014)
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Mingchao Xie et al.
NATURE MEDICINE (2014)
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Giulio Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Combined Deficiency of Tet1 and Tet2 Causes Epigenetic Abnormalities but Is Compatible with Postnatal Development
Meelad M. Dawlaty et al.
DEVELOPMENTAL CELL (2013)
TET enzymes, TDG and the dynamics of DNA demethylation
Rahul M. Kohli et al.
NATURE (2013)
Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies
Zhe Li et al.
BLOOD (2011)
The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes
Tian-Peng Gu et al.
NATURE (2011)
Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
Myunggon Ko et al.
NATURE (2010)
Sensitive enzymatic quantification of 5-hydroxymethylcytosine in genomic DNA
Aleksandra Szwagierczak et al.
NUCLEIC ACIDS RESEARCH (2010)
Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms
Anna M. Jankowska et al.
BLOOD (2009)
Mutation in TET2 in Myeloid Cancers
Francois Delhommeau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Share Paper
